BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomeer M, Grutters JC, Wuyts WA, Willems S, Demedts MG. Clinical use of biomarkers of survival in pulmonary fibrosis. Respir Res 2010;11:89. [PMID: 20584284 DOI: 10.1186/1465-9921-11-89] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Yang Z, Han R, Yin H, Li J, Cao Y, Guo R, Sheng Y, Song L, Zhang Y. Mechanism of Lycopodii herba for RA-ILD using integrated metabolomics and network pharmacology. Analytical Biochemistry 2022. [DOI: 10.1016/j.ab.2022.114679] [Reference Citation Analysis]
2 Saeed ZH, Magdy MH, Abdelnaem EA, Mahmoud MM. Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases. Egypt J Bronchol 2020;14. [DOI: 10.1186/s43168-020-00043-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kwee TC, Torigian DA, Alavi A. Nononcological Applications of Positron Emission Tomography for Evaluation of the Thorax. Journal of Thoracic Imaging 2013;28:25-39. [DOI: 10.1097/rti.0b013e31827882a9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
4 Bauer Y, Tedrow J, de Bernard S, Birker-Robaczewska M, Gibson KF, Guardela BJ, Hess P, Klenk A, Lindell KO, Poirey S, Renault B, Rey M, Weber E, Nayler O, Kaminski N. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2015;52:217-31. [PMID: 25029475 DOI: 10.1165/rcmb.2013-0310OC] [Cited by in Crossref: 98] [Cited by in F6Publishing: 59] [Article Influence: 14.0] [Reference Citation Analysis]
5 Erdal BS, Crouser ED, Yildiz V, King MA, Patterson AT, Knopp MV, Clymer BD. Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis. Chest 2012;142:1589-97. [PMID: 22628487 DOI: 10.1378/chest.11-2027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
6 Kahn N, Rossler AK, Hornemann K, Muley T, Grünig E, Schmidt W, Herth FJF, Kreuter M. C-proSP-B: A Possible Biomarker for Pulmonary Diseases? Respiration 2018;96:117-26. [PMID: 29763900 DOI: 10.1159/000488245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Huang Y, Ma SF, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, Strek ME, White SR, Hogarth DK, Sandbo NK, Lussier YA, Gibson KF, Kaminski N, Garcia JG, Noth I. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulm Med 2015;15:147. [PMID: 26589497 DOI: 10.1186/s12890-015-0142-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
8 Ishikawa N, Hattori N, Yokoyama A, Kohno N. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Respir Investig. 2012;50:3-13. [PMID: 22554854 DOI: 10.1016/j.resinv.2012.02.001] [Cited by in Crossref: 162] [Cited by in F6Publishing: 161] [Article Influence: 16.2] [Reference Citation Analysis]
9 Song JW, Do KH, Jang SJ, Colby TV, Han S, Kim DS. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis. Chest. 2013;143:1422-1429. [PMID: 23715088 DOI: 10.1378/chest.11-2735] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 8.8] [Reference Citation Analysis]
10 Cicchitto G, Sanguinetti CM. Idiopathic pulmonary fibrosis: the need for early diagnosis. Multidiscip Respir Med 2013;8:53. [PMID: 23937857 DOI: 10.1186/2049-6958-8-53] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Blanco JR, Cobos-Ceballos MJ, Navarro F, Sanjoaquin I, Arnaiz de Las Revillas F, Bernal E, Buzon-Martin L, Viribay M, Romero L, Espejo-Perez S, Valencia B, Ibañez D, Ferrer-Pargada D, Malia D, Gutierrez-Herrero FG, Olalla J, Jurado-Gamez B, Ugedo J. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect 2021;27:892-6. [PMID: 33662544 DOI: 10.1016/j.cmi.2021.02.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
12 Cai Y, Zhu L, Zhang F, Niu G, Lee S, Kimura S, Chen X. Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs). Mol Pharm 2013;10:2237-47. [PMID: 23607644 DOI: 10.1021/mp300613x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
13 Lee EY, Wong CS, Fung SL, Yan PK, Ho JC. SUV as an adjunct in evaluating disease activity in idiopathic pulmonary fibrosis - a pilot study. Nucl Med Commun 2014;35:631-7. [PMID: 24472818 DOI: 10.1097/MNM.0000000000000083] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
14 Rusanov V, Kramer MR, Raviv Y, Medalion B, Guber A, Shitrit D. The Significance of Elevated Tumor Markers Among Patients With Idiopathic Pulmonary Fibrosis Before and After Lung Transplantation. Chest 2012;141:1047-54. [DOI: 10.1378/chest.11-0284] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
15 Fijačko V, Labor M, Fijačko M, Škrinjarić-Cincar S, Labor S, Dumbović Dubravčić I, Bačun T, Včev A, Popović-Grle S, Plavec D. Predictors of short-term LAMA ineffectiveness in treatment naïve patients with moderate to severe COPD. Wien Klin Wochenschr 2018;130:247-58. [PMID: 29322375 DOI: 10.1007/s00508-017-1307-7] [Reference Citation Analysis]
16 Flechsig P, Mehndiratta A, Haberkorn U, Kratochwil C, Giesel FL. PET/MRI and PET/CT in Lung Lesions and Thoracic Malignancies. Seminars in Nuclear Medicine 2015;45:268-81. [DOI: 10.1053/j.semnuclmed.2015.03.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
17 Leeming DJ, Sand JM, Nielsen MJ, Genovese F, Martinez FJ, Hogaboam CM, Han MK, Klickstein LB, Karsdal MA. Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis. Biomark Insights 2012;7:119-26. [PMID: 23012495 DOI: 10.4137/BMI.S9415] [Cited by in Crossref: 59] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
18 Miyazaki Y, Tsutsui T, Inase N. Treatment and monitoring of hypersensitivity pneumonitis. Expert Review of Clinical Immunology 2016;12:953-62. [DOI: 10.1080/1744666x.2016.1182426] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
19 Horimasu Y, Hattori N, Ishikawa N, Tanaka S, Bonella F, Ohshimo S, Guzman J, Costabel U, Kohno N. Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms. BMC Med Genet 2014;15:4. [PMID: 24400879 DOI: 10.1186/1471-2350-15-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
20 Wuyts WA, Thomeer M, Demedts MG. Newer modes of treating interstitial lung disease. Curr Opin Pulm Med 2011;17:332-6. [PMID: 21597376 DOI: 10.1097/MCP.0b013e3283483e76] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]